Analyst Ranking
Top 23%
#1136 out of 5020 analysts
Average Return
+8.22%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good

Subbu Nambi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Natera IncNTRA
+176.34%$60.27$166.55
2023-12-13 -
2024-12-13
Strong Buy
Tempus Ai IncTEM
+85.91%$46.50$86.45
2024-12-08 -
2025-09-17
Strong Buy
Guardant Health IncGH
+76.11%$28.88$50.86
2024-06-27 -
2025-06-27
Strong Buy
Cryoport IncCYRX
+58.11%$5.61$8.87
2025-04-15 -
2025-09-17
Strong Buy
Castle Biosciences IncCSTL
+40.08%$20.61$28.87
2023-12-13 -
2024-12-13
Strong Buy

Subbu Nambi Analyst Color

Get additional color on Subbu Nambi's coverage of popular stocks

Subbu Nambi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Caris Life Sciences IncCAI
2Strong Buy$36.00+7.37%Maintains
a month ago
Danaher CorpDHR
2Strong Buy$250.00+29.57%Reiterates
2 months ago
Genedx Holdings CorpWGS
1Strong Buy$115.00-10.10%Maintains
3 months ago
Tempus Ai IncTEM
2Strong Buy$75.00-13.24%Maintains
3 months ago
Neogen CorpNEOG
3Strong Buy$10.00+83.15%Maintains
3 months ago
Illumina IncILMN
3Strong Buy$114.00+13.02%Maintains
4 months ago
Twist Bioscience CorpTWST
2Strong Buy$50.00+85.39%Reiterates
4 months ago
Cryoport IncCYRX
1Strong Buy$10.00+12.74%Reiterates
5 months ago
Exact Sciences CorpEXAS
2Strong Buy$60.00+14.55%Reiterates
5 months ago
Veracyte IncVCYT
3Strong Buy$37.00+16.24%Maintains
5 months ago
Guardant Health IncGH
2Strong Buy$56.00-2.08%Reiterates
7 months ago
Natera IncNTRA
2Strong Buy$200.00+14.01%Maintains
8 months ago
Bruker CorpBRKR
1Strong Buy$72.00+124.23%Initiates Coverage On
9 months ago
Sophia Genetics SaSOPH
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Nautilus Biotechnology IncNAUT
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Castle Biosciences IncCSTL
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Myriad Genetics IncMYGN
1Strong Buy$23.00N/AInitiates Coverage On
2 years ago
10x Genomics IncTXG
1Strong Buy$60.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.